首页> 外文期刊>Fundamental & clinical pharmacology. >The pharmacokinetic-pharmacodynamic model of telmisartan and hydrochlorothiazide on blood pressure and plasma potassium after long-term administration in spontaneously hypertensive rats
【24h】

The pharmacokinetic-pharmacodynamic model of telmisartan and hydrochlorothiazide on blood pressure and plasma potassium after long-term administration in spontaneously hypertensive rats

机译:在自发性高血压大鼠中长期施用后替米沙坦和盐酸血压和血浆钾的药代动力学药物动力学模型

获取原文
获取原文并翻译 | 示例

摘要

A pharmacokinetic-pharmacodynamic model was developed to describe the time course of blood pressure and plasma potassium after long-term telmisartan and/or hydrochlorothiazide administration in spontaneously hypertensive rats. The spontaneously hypertensive rats were administered once daily for 6 weeks. The drug concentration, blood pressure and plasma potassium were monitored for several points. The time courses of blood pressure and plasma potassium were described by indirect response pharmacokinetic-pharmacodynamic model. The synergistic antihypertensive pharmacodynamic interaction between telmisartan and hydrochlorothiazide was observed, which was simulated by the inhibitory function of telmisartan and stimulatory function of hydrochlorothiazide after co-administration of the two drugs. For plasma potassium, when hydrochlorothiazide administrated alone, the plasma potassium reached to a low steady-state level at 4.64 mmol/L for 6 weeks. The plasma potassium increased to a steady-state level at 4.84 mmol/L after co-administration of telmisartan. The time courses of plasma potassium were successfully characterized by indirect response pharmacokinetic-pharmacodynamic model after long-term administration of telmisartan and/or hydrochlorothiazide. The model captured turnovers of blood pressure and plasma potassium in the different time phases and dose conditions.
机译:制定了药代动力学药物动力学模型,描述了在自发性高血压大鼠中长期Telmisartan和/或氢氯噻嗪给药后的血压和血浆钾的时间过程。自发性高血压大鼠每天服用6周给药。监测药物浓度,血压和血浆钾的几点。间接反应药代动力学 - 药效模型描述了血压和等离子体钾的时间课程。观察到替米沙坦和氢氯噻嗪之间的协同抗高血压药物动力学相互作用,其通过综合氧化物在两种药物共施用后筛选和氢氯噻嗪的刺激功能模拟。对于血浆钾,当单独氢氯噻嗪施用时,等离子体钾达到4.64mmol / L的低稳态水平6周。在替米沙坦共同施用后,血浆钾在4.84mmol / L的稳态水平上升。通过在长期施用Telmisartan和/或氢氯噻嗪后的间接反应药代动力学药物动力学模型成功地表征了血浆钾的时间疗程。模型在不同时间阶段和剂量条件下捕获血压和等离子体钾的失误。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号